<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>BNF 89</title>
    <subTitle>march-september 2025</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Joint Formulary Committee</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="text">London</placeTerm>
    </place>
    <publisher>BMJ Group</publisher>
    <dateIssued>2025</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <physicalDescription>
    <extent>xvii, 1998 p. ; 21 cm. : ill., Col.</extent>
  </physicalDescription>
  <note>Includes index.</note>
  <subject>
    <topic>Drug formularies Endocrine system</topic>
    <topic>Cardiovascular system</topic>
    <topic>Respiratory sysytem</topic>
    <topic>Nervous system</topic>
    <topic>Medicine therapy</topic>
    <topic>Eye</topic>
    <topic>Vaccines</topic>
    <topic>IIMC</topic>
    <topic>FHMS</topic>
  </subject>
  <classification authority="ddc">615.13 BNF</classification>
  <identifier type="isbn">9780857114877 (pbk)</identifier>
  <recordInfo/>
</mods>
